Table 1: Characteristics of the studies included in the analysis.
|
Publication Date |
Authors |
Journal |
Location |
Type of Study |
No. participants |
Males |
Smokers |
Mortality |
|
24032020 |
Emami A; et al. [13] |
Arch Acad Emerg Med 2020;8(1): e35 |
Shiraz, Iran |
Systematic review and meta-analysis |
3403 |
57,97% |
7.63% |
& |
|
21022020 |
Lupia T; et al. [15] |
Viruses. 2020 Feb; 12(2): 135. |
Turin, Italy |
Systematic review |
76993 |
56% |
2% |
&& |
|
2020 |
Harris C; et al. [14] |
J Global Health 2002 Jun 10(1):011001 |
Edinburgh, UK |
Systematic review |
|
|
|
&& |
|
20032020 |
Vardavas CI, et al. [12] |
Tob Induc Dis 2020; 18:20 |
Boston, USA |
Systematic review |
1099 |
|
&&& |
Uninformed |
|
2020 |
Guan W; et al.[19] |
Eur Respir J 2020 Mar 26:2000547 |
Wuhan, China |
Retrospective study |
1590 |
59,30% |
3,10% |
&* |
|
29012020 |
Chen N; et al. [17] |
Lancet 2020; 15- 21Feb;395(10223):507-513 |
Wuhan, China |
Retrospective study |
99 |
67,67% |
11% |
58% |
|
27032020 |
Guo T; et al. [1] |
J Glob Antimicrob Resist 2020 Mar 7 |
Wuhan, China |
Retrospective study |
187 |
48,66% |
10,38% |
22,90% |
|
21022020 |
Yang X; et al. [20] |
Lancet respir Med 2020; Feb 28; 8(4): e26 |
Wuhan, China |
Retrospective study |
52 |
67,30% |
3,84% |
32% |
|
2020 |
Shi Y; et al. [18] |
Crit Care 2020; 24:108 |
Hangzhou, China |
Retrospective study |
487 |
53,18% |
8,21% |
61,50% |
|
20032020 |
Brake SJ; et al. [16] |
Tasmania, Australia |
Retrospective study |
|
|
|
&** |
|
|
18022020 |
Zhang J; et al. [21] |
Wuhan, China; Davos, Switzerland |
Retrospective study |
140 |
50,70% |
1,40% |
Uninformed |
&: smoking was not directly related to increased mortality, but rather to the occurrence of more severe COVID-20 pictures; &&: It mentions smoking as a risk factor for deaths by COVID-19; &&&: 2.4 times (RR=2.4, 95% CI: 1.43-4.04) more likely to be admitted to the intensive care unit, need mechanical ventilation or die; &*: It refers to the association between the increase in the number of comorbidities and the increase in mortality and hospitalization outcomes by COVID-19; &**: It refers to the association of men, elderly and the presence of comorbidities as unfavourable factors for mortality and hospitalization outcomes by COCID-19.